Editorial
doi: 10.1001/jama.2014.11322.
Treating COPD in the real world
Affiliations
- PMID: 25226474
- DOI: 10.1001/jama.2014.11322
Item in Clipboard
Editorial
Treating COPD in the real world
JAMA.
.
No abstract available
Comment on
-
Combination long-acting β-agonists and inhaled corticosteroids compared with long-acting β-agonists alone in older adults with chronic obstructive pulmonary disease.JAMA. 2014 Sep 17;312(11):1114-21. doi: 10.1001/jama.2014.11432. JAMA. 2014. PMID: 25226477
Similar articles
-
Long-acting β-agonists with vs without inhaled corticosteroids for COPD.JAMA. 2015 Jan 20;313(3):305. doi: 10.1001/jama.2014.16470. JAMA. 2015. PMID: 25603004 No abstract available.
-
Long-acting β-agonists with vs without inhaled corticosteroids for COPD--reply.JAMA. 2015 Jan 20;313(3):305-6. doi: 10.1001/jama.2014.16479. JAMA. 2015. PMID: 25603005 No abstract available.
-
[Inhalation steroids in COPD: of value only for asthma patients!].MMW Fortschr Med. 2003 Oct 30;145(44):16. MMW Fortschr Med. 2003. PMID: 14655500 German. No abstract available.
-
Clinical Inquiry: what are the benefits and risks of inhaled corticosteroids for COPD?J Fam Pract. 2014 May;63(5):276-8. J Fam Pract. 2014. PMID: 24795909 Review. No abstract available.
-
Achieving therapeutic benefits of inhaled corticosteroids/beta2 agonist in chronic obstructive airway disease.Chin Med J (Engl). 2007 Jun 20;120(12):1097-105. Chin Med J (Engl). 2007. PMID: 17637229 Review. No abstract available.
Cited by
-
LAMA/LABA vs ICS/LABA in the treatment of COPD in Japan based on the disease phenotypes.Int J Chron Obstruct Pulmon Dis. 2015 Jun 10;10:1093-102. doi: 10.2147/COPD.S72858. eCollection 2015. Int J Chron Obstruct Pulmon Dis. 2015. PMID: 26089659 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
